Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.

• Rigel Announces First Quarter 2013 Financial Results
  
  

Rigel Profiled in IN VIVO

• Rigel Pharmaceuticals, Inc.
  2013 Annual Meeting
  Held May 14, 2013
  South San Francisco, CA